Vimarsana
Biggest News Aggregation in the World

Page 13 - Life Sciences Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Life Sciences Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Life Sciences Ltd Today - Breaking & Trending Today

Ketoanalogue for Kidney Disease Market to be Worth US$ 409.6 Mn by the End 2031 - Vimarsana News

Ketoanalogue for Kidney Disease Market to be Worth US$ 409.6 Mn by the End 2031

Ketoanalogue for Kidney Disease Market to be Worth US$ 409.6 Mn by the End 2031

DelveInsight Business Research, LLP: A Comprehensive Analysis of 250+ Key Companies Strengthening Gene Therapy Clinical Trial Pipeline - Vimarsana News

DelveInsight Business Research, LLP: A Comprehensive Analysis of 250+ Key Companies Strengthening Gene Therapy Clinical Trial Pipeline

Gene therapy clinical trial pipeline constitutes 250+ key companies continuously working towards developing 300+ gene therapies, analyzes DelveInsight LAS VEGAS, Nov. 2, 2022 /PRNewswire/

A Comprehensive Analysis of 250+ Key Companies Strengthening Gene Therapy Clinical Trial Pipeline - Vimarsana News

A Comprehensive Analysis of 250+ Key Companies Strengthening Gene Therapy Clinical Trial Pipeline

/PRNewswire/ -- DelveInsight's 'Gene Therapy Competitive Landscape – 2022' report provides comprehensive global coverage of available, marketed, and pipeline...

Glenmark Life Sciences Ltd Q2FY23 PAT slips to Rs. 106.87 crores - Vimarsana News

Glenmark Life Sciences Ltd Q2FY23 PAT slips to Rs. 106.87 crores

The Board of Directors of Glenmark Life Sciences Limited, at its meeting held today have approved the financial results of the company for the period ended September 30, 2022 - Q2FY23 and H1FY23.

Tiziana Life Sciences Ltd.: Tiziana Life Sciences Ltd Invites You to Join Us at The ThinkEquity Conference - Vimarsana News

Tiziana Life Sciences Ltd.: Tiziana Life Sciences Ltd Invites You to Join Us at The ThinkEquity Conference

NEW YORK, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd (NASDAQ: TLSA), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, will